Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 433

1.

Multi-center randomized controlled trial of cognitive treatment, placebo, oxybutynin, bladder training, and pelvic floor training in children with functional urinary incontinence.

van Gool JD, de Jong TP, Winkler-Seinstra P, Tamminen-Möbius T, Lax H, Hirche H, Nijman RJ, Hjälmås K, Jodal U, Bachmann H, Hoebeke P, Walle JV, Misselwitz J, John U, Bael A; European Bladder Dysfunction Study (EU BMH1-CT94-1006).

Neurourol Urodyn. 2014 Jun;33(5):482-7. doi: 10.1002/nau.22446. Epub 2013 Jun 15.

PMID:
23775924
2.

The relevance of urodynamic studies for Urge syndrome and dysfunctional voiding: a multicenter controlled trial in children.

Bael A, Lax H, de Jong TP, Hoebeke P, Nijman RJ, Sixt R, Verhulst J, Hirche H, van Gool JD; European Bladder Dysfunction Study (European Union BMH1-CT94-1006).

J Urol. 2008 Oct;180(4):1486-93; discussion 1494-5. doi: 10.1016/j.juro.2008.06.054. Epub 2008 Aug 16.

PMID:
18710726
3.

Pre-operative opening detrusor pressure is predictive of detrusor overactivity following TVT in patients with pre-operative mixed urinary incontinence.

Panayi DC, Duckett J, Digesu GA, Camarata M, Basu M, Khullar V.

Neurourol Urodyn. 2009;28(1):82-5. doi: 10.1002/nau.20576.

PMID:
19089898
4.

Comparison of biofeedback therapy in children with treatment-refractory dysfunctional voiding and overactive bladder.

Tugtepe H, Thomas DT, Ergun R, Abdullayev T, Kastarli C, Kaynak A, Dagli TE.

Urology. 2015 Apr;85(4):900-4. doi: 10.1016/j.urology.2014.12.031. Epub 2015 Feb 7.

PMID:
25669732
5.

Prospective randomized comparison of oxybutynin, functional electrostimulation, and pelvic floor training for treatment of detrusor overactivity in women.

Arruda RM, Castro RA, Sousa GC, Sartori MG, Baracat EC, Girão MJ.

Int Urogynecol J Pelvic Floor Dysfunct. 2008 Aug;19(8):1055-61. doi: 10.1007/s00192-008-0586-y. Epub 2008 Mar 11.

PMID:
18330483
6.

The lazy bladder syndrome: a possible urodynamic evolution in patients with idiopatic detrusor and pelvic floor overactivity.

Merlini E, Sangiorgio L, Seymandi P.

Pediatr Med Chir. 2004 May-Jun;26(3):187-90.

PMID:
16366402
7.

Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women.

Goode PS, Burgio KL, Locher JL, Umlauf MG, Lloyd LK, Roth DL.

J Am Geriatr Soc. 2002 May;50(5):808-16.

PMID:
12028165
8.

Central inhibition of refractory overactive bladder complaints, results of an inpatient training program.

Meijer EF, Nieuwhof-Leppink AJ, Dekker-Vasse E, de Joode-Smink GC, de Jong TP.

J Pediatr Urol. 2015 Feb;11(1):21.e1-5. doi: 10.1016/j.jpurol.2014.06.024. Epub 2014 Aug 11.

PMID:
25205144
9.

Anticholinergic drugs versus non-drug active therapies for overactive bladder syndrome in adults.

Alhasso AA, McKinlay J, Patrick K, Stewart L.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003193. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD003193.

PMID:
17054163
10.

Comparison between oxybutynin, functional electrical stimulation and pelvic floor training for treatment of detrusor overactivity in women: a review.

Arruda RM, Castro R, Sartori M, Girão MJ.

Curr Opin Obstet Gynecol. 2009 Oct;21(5):412-4. doi: 10.1097/GCO.0b013e32832fd28f. Review.

PMID:
19593131
11.

The role of urinary nerve growth factor for the diagnosis and assessment of the biofeedback success in children with dysfunctional voiding.

Ergin G, Kibar Y, Ebiloğlu T, Irkılata HC, Kopru B, Kaya E, Uyanık M, Tapan S, Dayanc MM.

J Pediatr Urol. 2016 Apr;12(2):118.e1-6. doi: 10.1016/j.jpurol.2015.09.015. Epub 2015 Nov 22.

PMID:
26701107
12.

Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.

Dokmeci F, Cetinkaya SE, Seval MM, Dai O.

Eur J Obstet Gynecol Reprod Biol. 2017 May;212:126-131. doi: 10.1016/j.ejogrb.2017.03.023. Epub 2017 Mar 18.

PMID:
28355584
13.

Classification and treatment of functional incontinence in children.

Nijman RJ.

BJU Int. 2000 May;85 Suppl 3:37-42; discussion 45-6. Review.

14.

Urodynamic evaluation of the bladder and pelvic floor.

Bradley CS, Smith KE, Kreder KJ.

Gastroenterol Clin North Am. 2008 Sep;37(3):539-52, vii. doi: 10.1016/j.gtc.2008.06.006. Review.

PMID:
18793995
15.

Cizolirtine citrate is safe and effective for treating urinary incontinence secondary to overactive bladder: a phase 2 proof-of-concept study.

Zát'ura F, Vsetica J, Abadías M, Pavlík I, Schraml P, Brod'ák M, Villoria J, Sust M; E-4018/CL50 Study Group.

Eur Urol. 2010 Jan;57(1):145-52. doi: 10.1016/j.eururo.2009.04.045. Epub 2009 May 7.

PMID:
19446951
16.

OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.

Chapple C, Sievert KD, MacDiarmid S, Khullar V, Radziszewski P, Nardo C, Thompson C, Zhou J, Haag-Molkenteller C.

Eur Urol. 2013 Aug;64(2):249-56. doi: 10.1016/j.eururo.2013.04.001. Epub 2013 Apr 10.

PMID:
23608668
17.

Effect of pelvic floor interferential electrostimulation on urodynamic parameters and incontinency of children with myelomeningocele and detrusor overactivity.

Kajbafzadeh AM, Sharifi-Rad L, Baradaran N, Nejat F.

Urology. 2009 Aug;74(2):324-9. doi: 10.1016/j.urology.2008.12.085. Epub 2009 May 24.

PMID:
19476983
18.

The usefulness of a minimal urodynamic evaluation and pelvic floor biofeedback in children with chronic voiding dysfunction.

Pfister C, Dacher JN, Gaucher S, Liard-Zmuda A, Grise P, Mitrofanoff P.

BJU Int. 1999 Dec;84(9):1054-7.

PMID:
10571635
19.

Clinical and video urodynamic characteristics of adult women with dysfunctional voiding.

Chen YC, Kuo HC.

J Formos Med Assoc. 2014 Mar;113(3):161-5. doi: 10.1016/j.jfma.2012.04.008. Epub 2012 Aug 9.

20.

Short pelvic floor EMG lag time II: use in management and follow-up of children treated for detrusor overactivity.

Van Batavia JP, Combs AJ, Glassberg KI.

J Pediatr Urol. 2014 Apr;10(2):255-61. doi: 10.1016/j.jpurol.2013.10.013. Epub 2013 Nov 7.

PMID:
24291249

Supplemental Content

Support Center